247 related articles for article (PubMed ID: 19436813)
1. Late stent thrombosis associated with heavy exercise.
Simsek Z; Arslan S; Gundogdu F
Tex Heart Inst J; 2009; 36(2):154-7. PubMed ID: 19436813
[TBL] [Abstract][Full Text] [Related]
2. Bare metal stent thrombosis 13 years after implantation.
Sarkees ML; Bavry AA; Galla JM; Bhatt DL
Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
[TBL] [Abstract][Full Text] [Related]
4. Late or very late stent thrombosis can also occur with bare metal stents.
Ramos AR; Morice MC; Lefèvre T
Catheter Cardiovasc Interv; 2007 Aug; 70(2):229-32. PubMed ID: 17632773
[TBL] [Abstract][Full Text] [Related]
5. Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.
Yang EH; Perez E; Zhiroff KA; Burstein S
Tex Heart Inst J; 2011; 38(2):174-8. PubMed ID: 21494531
[TBL] [Abstract][Full Text] [Related]
6. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
7. Successful trapping of an organized thrombus in a coronary artery aneurysm in myocardial infarction: case report and literature review.
Härle T; Reimers J; Hertting K; Kuck KH
Cardiovasc Revasc Med; 2008; 9(1):52-5. PubMed ID: 18206639
[TBL] [Abstract][Full Text] [Related]
8. French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
Angioi M; Barragan P; Cattan S; Collet F; Dupouy P; Durand P; Fajadet J; Finet G; Gerardin B; Gommeaux A; Karsenty B; Loubeyre C; Meyer P; Morice MC; Moulichon MÉ; Sayah S; Silvestri M; Tabone X; Unterseeh T; Wittenberg O; Lablanche JM
Arch Cardiovasc Dis; 2012 Feb; 105(2):60-7. PubMed ID: 22424323
[TBL] [Abstract][Full Text] [Related]
9. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
[TBL] [Abstract][Full Text] [Related]
10. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions).
Eisenstein EL; Wijns W; Fajadet J; Mauri L; Edwards R; Cowper PA; Kong DF; Anstrom KJ
JACC Cardiovasc Interv; 2009 Dec; 2(12):1178-87. PubMed ID: 20129543
[TBL] [Abstract][Full Text] [Related]
14. Late coronary thrombosis in paclitaxel-eluting stents. Case reports.
Cassin M; De Biasio M; Macor F; Burelli C; Vendrametto F; Driussi M; Nicolosi GL
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):284-8. PubMed ID: 17413307
[TBL] [Abstract][Full Text] [Related]
15. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
[TBL] [Abstract][Full Text] [Related]
16. Very late bare metal stent thrombosis: The role of restenosis.
Sengül C; Erdoğan T; Dindar I
Turk Kardiyol Dern Ars; 2010 Jun; 38(4):282-4. PubMed ID: 20935438
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous subacute thrombosis in bare metal stents implanted into right coronary artery and left anterior descending artery without coexistence of resistance to antiplatelet therapy].
Frynas K; Krecki R; Krzemińska-Pakuła M; Kasprzak JD
Kardiol Pol; 2010 Sep; 68(9):1070-3; discussion 1074-5. PubMed ID: 20859908
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes after angiographically defined very late stent thrombosis of drug-eluting stent.
Kim U; Kim DK; Kim YB; Seol SH; Yang TH; Kim DK; Kim DI; Kim DS; Lee SH; Hong GR; Park JS; Shin DG; Kim YJ; Cho YK; Kim HS; Nam CW; Hur SH; Kim KB
Clin Cardiol; 2009 Sep; 32(9):526-9. PubMed ID: 19743488
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
[TBL] [Abstract][Full Text] [Related]
20. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
